Unbound MEDLINE

Characterization of natural killer (NK) and natural killer-like T (NKT) cells derived from ex-vivo expanded and activated cord blood mononuclear cells: Implications for adoptive cellular immunotherapy (ACI). Experimental hematology [Exp Hematol] Journal article

 
TitleCharacterization of natural killer (NK) and natural killer-like T (NKT) cells derived from ex-vivo expanded and activated cord blood mononuclear cells: Implications for adoptive cellular immunotherapy (ACI).
Author(s)Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS 
InstitutionDepartment of Pediatrics, Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University, New York, New York.
SourceExp Hematol 2009 Jul 25.
AbstractOBJECTIVE: Cord blood (CB) is limited by the absence of available donor effector cells for post unrelated CB transplantation (UCBT) adoptive cellular immunotherapy (ACI). We reported the ability to ex-vivo expand (EvE) CB MNC after short-term incubation with anti-CD3, IL-2, IL-7 and IL-12 (AB/CY) into subpopulations of CD3(-)/56(+) NK cells with enhanced in-vitro and in-vivo tumor cytotoxicity.
METHODS: We compared 2 vs 7 day EvE of rethawed CB MNCs in AB/CY and activation of NK and NKT-like (CD3(+)/56(+)) subsets expressing specific NK cell receptors (NKRs) along with IL-15, IL-18 and IFN-gamma production.
RESULTS: Non-adherent total cell number were significantly increased at day 7 (p<0.001) along with NK cell number (20-fold) and an enrichment in NKT-like subsets (36-fold). There was no change in the NK(dim) subset; yet, the NKT(bright) and NKT KIR3DL1(dim) subsets were significantly increased (p<0.05). NK cells expressing the inhibitory NCR CD94/NKG2A was decreased (p<0.001) while those expressing activating NCR CD94/NKG2D receptor, and activating NK and NKT KIR2DS4 subsets were significantly increased (p<0.001). IL-18 and IFN-gamma protein production was also significantly increased (p<0.001 and p<0.05, respectively). LAMP-1 and granzyme B expression were increased (p<0.001 and p>0.01, respectively) which correlated with the significant increase in NK, LAK and tumor cytotoxicity of the EvE cells.
CONCLUSION: This study demonstrates that previously cryopreserved and rethawed CB MNCs can be EvE up to 7 days to yield viable and activated NK and NKT-like subsets which appear to be cytolytic based on the cell repertoire and could be utilized in the future as ACI post UCBT.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19638292
  
Advertise on this site.